Johnson et al., 1992 - Google Patents
Pleiotropic effects of a null mutation in the c-fos proto-oncogeneJohnson et al., 1992
- Document ID
- 12229479762167824152
- Author
- Johnson R
- Spiegelman B
- Papaioannou V
- Publication year
- Publication venue
- Cell
External Links
Snippet
The c-fos proto-oncogene has been implicated as a central regulatory component of the nuclear response i: o mitogens and other extracellular stimuli. Embryonic stem cells targeted at the c-fos locus have been used i: o generate chimeric mice that have transmitted the …
- 102100002070 FOS 0 title abstract description 85
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Johnson et al. | Pleiotropic effects of a null mutation in the c-fos proto-oncogene | |
Shavit et al. | Impaired megakaryopoiesis and behavioral defects inmafG-null mutant mice | |
Zhuang et al. | The helix-loop-helix gene E2A is required for B cell formation | |
Berk et al. | Mice lacking the ski proto-oncogene have defects in neurulation, craniofacial patterning, and skeletal muscle development | |
Franklin et al. | CDK inhibitors p18INK4c and p27Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis | |
Luoh et al. | Zfx mutation results in small animal size and reduced germ cell number in male and female mice | |
Field et al. | E2F-1 functions in mice to promote apoptosis and suppress proliferation | |
Li et al. | Gsh‐4 encodes a LIM‐type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survival. | |
JP4669968B2 (en) | Methods for regulating hematopoiesis and angiogenesis | |
JPH08506014A (en) | Transgenic mammal | |
EP2050335A1 (en) | Gene disruptions, compositions and methods relating thereto | |
JP2009232849A (en) | Transgenic animal for different gene and their use for gene characterization | |
JP2008541781A5 (en) | ||
CA2370237A1 (en) | Methods for the diagnosis and treatment of metastatic prostate tumors | |
EP2002714A1 (en) | Novel gene disruptions, compositions and methods relating thereto | |
US20050009112A1 (en) | Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth | |
Bradley et al. | The essential haematopoietic transcription factor Scl is also critical for neuronal development | |
US20100061973A1 (en) | Graded Expression of Snail as Marker of Cancer Development and DNA Damage-Based Diseases | |
JP2001112373A (en) | Model mammal for onset of diabetes | |
JP2000515386A (en) | Ku-deficient cells and non-human transgenic animals | |
US6245965B1 (en) | Knockout mice and cells that lack p19INK4d and p27KIP1 activity and methods of use thereof | |
EP0922760A2 (en) | Transgenic animal not expressing endogenous osteoclastogenesis inhibitory factor (OCIF) | |
AU779476B2 (en) | Modulation of angiogenesis | |
WO1997038091A1 (en) | METHODS FOR ENHANCING ANIMAL GROWTH AND CELL PROLIFERATION BY ELIMINATION OF FUNCTIONAL p27?Kip1¿ | |
KR20100113594A (en) | Method for introducing foreign gene into early embryo of primate animal, and method for production of transgenic primate animal comprising the introduction method |